Morning, Marco. Busier news cycle than the last few days. Monday's executive order on
the childhood vaccine schedule detonated across every medical society this week, and it
lands in the same month a federal panel decides whether the US still has measles
elimination. Two solid clinical items underneath it — a new CDC mold surveillance report
with numbers worth remembering, and a study on night-shift work you'll want to read with
a slightly defensive posture. Coffee, then sleep.
A · Top Stories
Three items. All new since yesterday's edition.
Executive order would cut the childhood schedule and split the MMR — every major medical society has now objected
The August 10 executive order, "Delivering Gold Standard Childhood Vaccine
Recommendations for Americans," directs a rewrite of the childhood immunization
schedule — cutting the list of diseases all children are recommended to be vaccinated
against from 18 to 11 — and calls for the MMR to be broken into three standalone
shots. It also directs the Justice Department to sue states that don't provide
religious and medical exemptions to school mandates. CDC has already posted that it is
acting on the presidential memorandum.
The pushback arrived fast: the AAP, AMA, ACP, and a joint
APIC/SHEA statement
all came out against it in the last 72 hours. On Wednesday Merck told
Reuters
that separating the MMR could take up to a decade even on expedited pathways.
Why it matters to you
Two ways. First, timing: US measles sits at roughly 2,465 confirmed cases — the most in
35 years — and the national verification committee meets this month to decide
whether elimination status holds. Whatever happens to pediatric uptake shows up in your
ED as febrile-rash adults and in your isolation decisions. Second, precedent: this is
the schedule being set by executive action rather than by advisory committee, which is
the same machinery that governs the adult schedule you rely on for pneumococcal, RSV,
shingles, and flu in the 75-plus patients you admit every night.
Talking point: when a family asks you overnight whether the MMR is
"being changed," the accurate short answer is that no separate measles, mumps, or
rubella product is currently licensed or manufactured in the US, and the manufacturer's
own estimate is years out. Nothing available to a patient today has changed.
CIDRAP ·
CNN ·
EO text
New CDC surveillance on invasive mold disease: 45% dead at 90 days, and a third had no classic risk factors
MMWR published active laboratory-based surveillance from two Atlanta academic hospitals
and their clinics, 2020–2024. Of 968 patients flagged for possible invasive mold
disease, 449 met a case definition (89 confirmed, 142 probable, 218 surveillance).
Lungs were the site in 68%; skin/deep tissue 11%, sinus 10%, CNS 9%. Outcomes were
brutal: 43% went to ICU, 50% were intubated, and 45% were dead within 90 days.
The number to hold onto — 35% had none of the classic host risk factors
used to decide who gets worked up. And among the 13% with current or recent COVID, ICU
admission was 66% and 90-day mortality was 66%, versus 39% and 41% without.
Why it matters to you
This is a night-admission problem more than an oncology problem. The classic mental
model is neutropenia and transplant; this report says a third of cases sit outside it,
and that severe influenza and severe COVID are increasingly recognized as the entry
point. Your typical elderly patient who came in with viral pneumonia, got steroids,
improved, and then quietly stopped improving on day 4 is exactly the shape of the
missed case.
Action: worth a single question to ID or pharmacy — what triggers a
galactomannan or fungal work-up in a non-neutropenic post-viral patient who isn't
responding to antibacterials by day 3? If the answer is "the ID consult decides,"
that's a threshold problem, not a testing problem.
MMWR ·
CIDRAP summary
Night-shift work associated with an 88% higher risk of long COVID — and this one's about you, not your patients
A prospective analysis out of the Spanish COVICAT cohort (Medical University of Vienna
and ISGlobal), published in the Scandinavian Journal of Work, Environment &
Health, followed 1,899 people with confirmed COVID for two years. 14.9% developed
long COVID. After adjustment, night-shift workers were 88% more likely to develop it
than day workers (RR 1.88), with a dose relationship: three or more nights a month, or
three-plus months of night work, carried roughly double the risk (RR 2.07). Chronic
insomnia was an independent factor (RR 1.42); night work plus chronic insomnia together
ran 2.69. Neurologic symptoms dominated at 54%. Notably, night work was not
associated with a higher risk of getting infected — only with failing to recover.
Why it matters to you
You've been a nocturnist long enough that the exposure variable in this study is just
your job description. The authors' framing is that circadian disruption governs the
transition from acute infection to persistent symptoms, not susceptibility — which
means the modifiable piece is sleep quality on your off-days, not masking harder.
Coauthor Manolis Kogevinas puts the intervention plainly: protecting sleep is a
low-cost strategy, particularly for night workers. Caveat where it's due: observational,
single cohort, mostly Omicron-era mild infections, and the obesity-interaction subgroup
was small enough that the authors flag it themselves.
Action: nothing to order. But if your post-shift sleep has been
fragmented this summer, this is a reasonable nudge to treat that as a health variable
rather than an occupational tax.
SJWEH abstract ·
CIDRAP
B · The Debate
One topic, both sides, no verdict.
Should elected officials set the childhood vaccine schedule, or should it stay with expert advisory committees?
Monday's executive order took a document that has been drafted by CDC advisory
committees for decades and rewrote it by presidential directive — cutting recommended
disease coverage from 18 to 11, ordering the MMR split, and pointing the Justice
Department at states that refuse religious exemptions. Every major physician
organization objected within 48 hours. The underlying question isn't really about any
single vaccine; it's about who holds the pen.
The case for political accountability
The White House; HHS Secretary Robert F. Kennedy Jr.
The schedule is a government recommendation with enormous legal consequence — it
drives school mandates, insurance coverage, and liability protection — yet it is
drafted by an appointed committee that no voter can remove. Post-COVID, a
meaningful share of parents no longer accept "the experts decided" as sufficient,
and the resulting distrust is itself a public-health cost. On this view, giving
families a choice between a combination shot and standalone components, and
restoring wide religious-exemption availability, is a trust-building move rather
than an anti-vaccine one: a parent who would otherwise refuse everything may accept
a schedule they helped shape. A White House official framed the order as
"opening up a dialogue to encourage public trust"; Kennedy said the changes are
meant to give parents choices.
Executive order ·
JURIST on the DOJ provision
The case for expert committees
Andrew D. Racine, MD, PhD (AAP president); Willie Underwood III, MD, MPH (AMA president); ACP
A schedule is an evidence product, and nothing in the evidence base changed between
Friday and Monday. Racine's objection is that the order arrives with no new data
attached — "there is no new evidence to justify significant changes to childhood
immunization guidance" — while measles runs at a 35-year high and kids head back to
school. Underwood's argument is about the mechanism: altering a proven schedule
without credible evidence weakens confidence rather than building it. The ACP adds
a practical dimension — splitting combination shots means more copays, more visits,
and more missed doses, with the burden landing hardest on families least able to
absorb it.
AAP statement ·
AMA statement ·
ACP statement
Where it might land: three clocks are running at once — Merck's
estimate that a standalone MMR split is up to a decade out, DOJ litigation aimed at
states including New York, California, Maine, and Connecticut, and the US national
verification committee's measles-elimination review this month, with PAHO's decision in
November.
One question for ID, one sentence for the group, and a paper that says your schedule is a
risk factor. Protect the sleep, Marco.